Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer Age In this role Joined 2024 pay Source
Maria Palasis, Ph.D. Also a director
Principal Executive Officer
Title from the Form 4 dated Apr 1, 2026
60 Not stated Not stated $3,732,197
Jason Cavalier
Principal Financial Officer
Title from the Form 4 dated Apr 1, 2026
Not stated Not stated Not stated $1,303,960

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 4, 2025 · updated by the 8-K of Aug 1, 2025

Directors
5
serving now
Independent
4 of 5
stated in the proxy
Average tenure
6.0 years
from year joined
CEO also chairs the board
Yes
Maria Palasis, Ph.D.
Director Age On board Independent Committees Other public boards 2024 pay Source
Maria Palasis, Ph.D.
60 2015
10 years
Not independent None stated None stated Paid as CEO
C. Ann Merrifield
73 2019
6 years
Independent None stated None stated $61,419
W. Bradford Smith
69 2019
6 years
Independent None stated None stated $72,169
James R. Tobin
80 2022
3 years
Independent None stated TransMedics, Inc., Globus Medical Inc. $100,669
Nancy L. Snyderman, M.D., FACS
72 2020
5 years
Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

4 disclosed in the proxy filed Apr 4, 2025
Perceptive Advisors, LLC
Entities affiliated with Perceptive Advisors, LLC are shareholders of both us and LianBio; former directors Konstantin Poukalov and Michael Altman are each a Managing Director at Perceptive Advisors, LLC
Amount not stated

LianBio license agreement in which entities affiliated with Perceptive Advisors, LLC hold interests in both the company and LianBio

With LianBio Open in proxy
Perceptive Advisers, LLC and North Bridge Venture Partners
5% or greater holders of our common stock and entities with which certain of our directors are related
Amount not stated
2023

Private placement of common stock, pre-funded warrants and accompanying warrants under a Securities Purchase Agreement with the Investors

Perceptive Advisers, LLC and North Bridge Venture Partners
5% or greater holders of our common stock and entities with which certain of our directors are related
Amount not stated
2022

Ninth Amended and Restated Investor Rights Agreement providing registration rights for these holders' common stock, amended May 25, 2023

Each of our directors and executive officers
directors and executive officers of the company
Amount not stated

Indemnification agreements requiring the company to indemnify each director and executive officer to the fullest extent permitted by Delaware law

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support